The UF Clinical & Translational Science Institute is now accepting applications for the TL1 Predoctoral Training Grant, which provides Ph.D. students engaged in clinical or translational research with one to two years of financial support, and research training to develop the skills required to build a career in multidisciplinary clinical and translational research relevant to human health.  TL1 trainees must participate in the Clinical & Translational Science interdisciplinary concentration, which involves course and research requirements.  Predoctoral students entering their second or third year of graduate study in 2016-17 who have not completed their dissertation proposal defense are eligible to apply.  The CTSI welcomes applicants from any of its partner graduate programs across 11 UF colleges.  See the web page link below for more information.

The TL1 program emphasizes collaboration and team science, and TL1 trainees will be expected to form TL1 Teams of two or more students from different graduate programs to collaborate on some aspect of their dissertation research.  Preference will be given to applicants who apply as a team.  Dates for information sessions to discuss the TL1 program and answer questions will be held on the following dates.
Wednesday, March 9, 12:00-1:00 pm, room C1-17, Communicore Building
Wednesday, March 16, 3:00-4:00 pm, room C1-17, Communicore Building

Applications are due by 5:00 p.m. on Friday, March 25, 2016.


TL1 Trainees will receive the following grant support during the initial one-year funding period (August 16, 2016 - August 15, 2017), and a second year of funding may be awarded on the basis of performance and progress:
* Annual stipend ($23,376, which may be supplemented if below current stipend) plus tuition waiver & health insurance
* $2,500 for lab and training-related expenses; and
* $1,500 travel allowance to attend and present at the annual Translational Science conference.


Applicants must be US citizens or permanent residents, and submit a completed application form and supporting materials, including: (1) applicant statement;  (2) a research plan for the proposed project that describes must have both clinical/ translational and basic science components; and  (3) supporting materials from two proposed mentors (one basic science mentor and one clinical/ translational science mentor).

Finalists will be interviewed by the TL1 Advisory Committee on April 18-19, and successful applicants will be notified by April 29, 2016.

Up to seven new TL1 Trainees will be named with an anticipated start date of August 15, 2016.

* Eligibility Details, Program Requirements and Application Instructions:

**Please feel free to forward this information to prospective applicants or their research mentors**


TL1 Program Assistant:  Susan Gardner, [log in to unmask]<mailto:[log in to unmask]>, 294-8335, room CG-72F (Communicore)
TL1 Program Director:  Wayne T. McCormack, PhD, [log in to unmask]<mailto:[log in to unmask]>, 294-8334, room CG-72K